BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seery N, Butzkueven H, O'Brien TJ, Monif M. Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis. Autoimmun Rev 2022;21:103057. [PMID: 35092831 DOI: 10.1016/j.autrev.2022.103057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma Y, Wang J, Guo S, Meng Z, Ren Y, Xie Y, Wang M. Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis. Front Immunol 2023;13. [DOI: 10.3389/fimmu.2022.1064007] [Reference Citation Analysis]
2 Ramasubramanian B, Reddy VS, Chellappan V, Ramakrishna S. Emerging Materials, Wearables, and Diagnostic Advancements in Therapeutic Treatment of Brain Diseases. Biosensors (Basel) 2022;12. [PMID: 36551143 DOI: 10.3390/bios12121176] [Reference Citation Analysis]
3 He J, Chen K, Sui Y, Yang Q. Effects of N-methyl-D-aspartate receptor knockdown and hypoxia/reoxygenation injury on the neuronal proteome and transcriptome. Front Mol Neurosci 2022;15:1004375. [PMID: 36590918 DOI: 10.3389/fnmol.2022.1004375] [Reference Citation Analysis]
4 Zhang H, Wan Y, Mei Z, Xie C, Liu S, Nie H, Hu F, Xu R. Case Report: Rheumatoid meningitis with positive NMDAR antibody: A case treated with intravenous immunoglobulin. Front Immunol 2022;13:971934. [DOI: 10.3389/fimmu.2022.971934] [Reference Citation Analysis]